Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer
Clinical Breast Cancer · 2023
DOI: 10.1016/j.clbc.2023.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023. Verfasst von Italo Fernandes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Division of Research Support, Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Department of Clinical Pathology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: gustavo.schvartsman@einstein.br.
Zitieren
APA
Fernandes, I., Scorsato, A., Kaliks, R., Corpa, M., Damasceno, E., & Schvartsman, G. (2023). Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2023.07.007
Vancouver
Fernandes I, Scorsato A, Kaliks R, Corpa M, Damasceno E, Schvartsman G. Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer. Clinical Breast Cancer. 2023. doi:10.1016/j.clbc.2023.07.007
BibTeX
@article{Fernandes2023,
author = {Fernandes, Italo and Scorsato, Anderson and Kaliks, Rafael and Corpa, Marcus and Damasceno, Eduarda and Schvartsman, Gustavo},
title = {Tumor-Infiltrating Lymphocytes in HER2-Low Breast Cancer},
journal = {Clinical Breast Cancer},
year = {2023},
doi = {10.1016/j.clbc.2023.07.007}
}
EUVIMED